Hero Image

5 Medications Linked to Alzheimer’s: What to Know

Some common medicines have been associated with a higher risk of dementia in observational studies.

That doesn’t mean these drugs cause Alzheimer’s, but it is a good reason to learn which medications may be linked to Alzheimer’s, how risk might arise, and the safer options you can ask about.

Are medicines really linked to Alzheimer’s?

Large observational studies suggest that certain drugs — especially those with strong anticholinergic effects — are associated with a higher chance of developing dementia later on. For example, a JAMA Internal Medicine study found a dose–response relationship between cumulative exposure to strong anticholinergic medicines and dementia risk, meaning higher lifetime exposure was linked to higher risk (Gray et al., 2015). A subsequent BMJ analysis also reported increased odds, particularly for antidepressants with anticholinergic effects and bladder antimuscarinics (Coupland et al., 2019). Still, association is not causation — some of the conditions these drugs treat (e.g., anxiety, insomnia) may themselves signal early, “prodromal” brain changes.

Risk appears to be influenced by dose and duration, age (higher in older adults), and the total “anticholinergic burden.” Geriatrics experts flag many of these medicines in the American Geriatrics Society Beers Criteria and recommend minimizing them when possible. Tools that estimate anticholinergic burden can help guide conversations (see the NHS Specialist Pharmacy Service overview on anticholinergic burden). Never stop a prescription on your own — some drugs require slow tapers to avoid withdrawal or rebound symptoms.

5 medication types to discuss with your doctor

1) Overactive bladder anticholinergics (e.g., oxybutynin, tolterodine)

These medications calm bladder spasms by blocking acetylcholine, a neurotransmitter crucial for memory. High cumulative exposure to bladder antimuscarinics has been linked with elevated dementia risk in cohort studies (BMJ 2019). If you take these long-term, ask whether a non-anticholinergic option like mirabegron (a beta-3 agonist) or pelvic floor therapy could work for you.

2) First-generation antihistamines and many OTC “PM” sleep aids

Diphenhydramine and doxylamine commonly appear in allergy pills and nighttime pain relievers. They are strongly anticholinergic and can cloud thinking, cause daytime sedation, and may contribute to long-term risk when used chronically. For allergies, consider non-sedating options (cetirizine, loratadine, fexofenadine). For sleep, behavioral approaches like CBT‑I are first-line and often more effective than pills.

3) Tricyclic antidepressants (e.g., amitriptyline, imipramine)

TCAs can be helpful for depression, anxiety, and nerve pain, but many have strong anticholinergic effects. Observational data suggest higher cumulative anticholinergic exposure is associated with increased dementia risk over time (JAMA IM 2015; BMJ 2019). If you’re on a TCA primarily for sleep or pain, ask about alternatives such as SNRIs (e.g., duloxetine), SSRIs for mood, or non-drug strategies (graded exercise, physical therapy, CBT).

4) Benzodiazepines for anxiety/insomnia (e.g., diazepam, lorazepam)

Evidence here is mixed: some studies suggest a link between past benzodiazepine use and later Alzheimer’s diagnosis, while others argue the drugs may simply mark early symptoms (anxiety, insomnia) rather than cause the disease. A frequently cited study reported higher Alzheimer’s risk with longer-term use (BMJ 2014), but confounding remains a concern. Regardless, long-term benzodiazepines can impair memory, increase falls, and cause dependence; gradual tapering and non-drug therapies (CBT, mindfulness, SSRIs/SNRIs when indicated) are preferred for chronic symptoms.

5) Proton pump inhibitors (PPIs) for reflux (e.g., omeprazole)

Early reports raised concerns about PPIs and dementia, but newer, better-controlled analyses have not confirmed a strong causal link. If PPIs are needed for clear indications (e.g., erosive esophagitis), benefits can outweigh risks. Be aware that long-term use may contribute to vitamin B12 or magnesium deficiency; periodic reassessment and the lowest effective dose are prudent (Mayo Clinic). If you’ve been on a PPI for months, ask about stepping down to an H2 blocker, on-demand use, or lifestyle changes.

How big is the risk?

In some studies, the highest cumulative exposure to strong anticholinergics was associated with roughly 40–60% higher odds of dementia compared with little or no exposure (Coupland et al., 2019). That sounds large, but remember: (1) odds are not the same as absolute risk; (2) these are associations, not proof of causation; and (3) for an individual, the benefit of a medication can still outweigh potential risk. The goal isn’t to avoid needed drugs — it’s to minimize brain-unfriendly exposure when reasonable alternatives exist.

How to protect your brain while using medicine

1) Review your medication list for anticholinergic burden

Ask your clinician or pharmacist to review all prescriptions, over-the-counter products, and supplements. Look for multiple drugs with anticholinergic effects and see where you can deprescribe or substitute. The Beers Criteria and this NHS overview of anticholinergic burden are good starting points.

2) Ask about safer alternatives

  • Bladder symptoms: Consider mirabegron, pelvic floor therapy, timed voiding.
  • Allergies: Try non-sedating antihistamines (cetirizine, loratadine) and nasal steroids or rinses.
  • Sleep: Start with CBT‑I, sleep hygiene, and circadian strategies before medications.
  • Mood/anxiety: Psychotherapies, SSRIs/SNRIs, and lifestyle measures often outperform chronic sedatives.

3) Taper cautiously — never stop abruptly

Benzodiazepines, sedative-hypnotics, certain antidepressants, and even OTC sleep aids can cause rebound symptoms or withdrawal if stopped suddenly. Work with your prescriber on a slow, individualized taper and an “exit plan” that includes non-drug supports.

4) Double down on brain-healthy habits

  • Control vascular risks: Manage blood pressure, cholesterol, blood sugar, and don’t smoke. These are among the strongest modifiable dementia risks.
  • Move your body: Aim for at least 150 minutes/week of moderate activity.
  • Eat for your brain: A Mediterranean-style pattern is linked with better cognitive aging.
  • Protect hearing and sleep: Treat hearing loss (a key modifiable risk per the Lancet Commission) and aim for 7–8 hours of quality sleep.
  • Stay socially and cognitively engaged: Purposeful activity matters.

For an evidence overview on prevention, see the National Institute on Aging’s summary: What do we know about preventing Alzheimer’s?

When to talk to a doctor

  • You take one or more medicines listed above — especially daily for months — and you’re 60+ or have memory concerns.
  • You notice new confusion, sedation, or falls after starting or increasing a medication.
  • You’re using benzodiazepines or OTC “PM” products regularly for sleep or anxiety.
  • You’ve been on a PPI longer than a few months without a clear ongoing indication.
  • You want help building a plan to reduce anticholinergic burden safely.

Key takeaways

  • Some medications — particularly those with strong anticholinergic effects — are associated with higher dementia risk over time.
  • Associations don’t prove causation, but minimizing anticholinergic burden and chronic sedative use is a prudent brain-protection strategy.
  • Never stop medicines abruptly; ask about safer alternatives and taper plans.
  • Healthy lifestyle and cardiovascular risk control remain the most evidence-based ways to protect brain health.

This article is for education only and is not a substitute for personal medical advice. Always discuss medication changes with your healthcare professional.